ANTONIO
OSUNA ORTEGA
COLABORADOR EXTRAORDINARIO
Institute of Clinical and Experimental Medicine
Praga, República ChecaPublicaciones en colaboración con investigadores/as de Institute of Clinical and Experimental Medicine (1)
2019
-
Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study
Transplantation, Vol. 103, Núm. 9, pp. 1953-1963